CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate
  • CRI Names Winners of Top Scientific Prize

    Four scientists to be honored with the 2014 Coley Award for their contributions to the discovery of…

    September 3, 2014| Matthew Tontonoz
  • When AIDS Was a Cancer

    Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…

    August 8, 2014| Matthew Tontonoz
  • Two Immunotherapies Clear Important Regulatory Hurdles

    The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…

    July 8, 2014| Matthew Tontonoz
  • Making Pancreatic Cancer a Target for Immunotherapy

    Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.

    June 18, 2014| Matthew Tontonoz
  • Immunotherapy Today: The View from ASCO

    Once again, immunotherapy stole the show at the world’s largest annual cancer meeting.

    June 9, 2014| Matthew Tontonoz
  • Immunotherapy All the Rage at AACR

    Researchers at this year's AACR annual meeting couldn’t stop talking about the promise of immunotherapy.

    April 21, 2014| Matthew Tontonoz
  • Putting a Hurt on Pancreatic Cancer

    CRI postdoc Ingunn Stromnes, PhD, shows that dismantling a tumor’s defense shield makes it vulnerable to immune…

    March 24, 2014| Matthew Tontonoz
  • Do Bacteria Cause Cancer?

    In honor of colorectal cancer awareness month, a look back at our understanding of the role of…

    March 10, 2014| Matthew Tontonoz
  • CRI Scientific Advisor James Allison Wins 2014 Szent-Györgyi Prize

    CRI Scientific Advisor James P. Allison, PhD, was awarded the 2014 Szent-Györgyi Prize by the National Foundation…

    February 12, 2014| Matthew Tontonoz

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute